Hartline Investment Corp Abb Vie Inc. Transaction History

Hartline Investment Corp

$795 Million
Q3 2024

A detailed history of Hartline Investment Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Hartline Investment Corp holds 8,815 shares of ABBV stock, worth $1.55 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

8,815

Previous 8,815 -0.0%

Holding current value

$1.55 Million

Previous $1.51 Million 15.16%

% of portfolio

0.22%

Previous 0.2%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$154.79 - $180.76 $263,452 - $307,653	-1,702 Reduced 16.18%	8,815 $1.51 Million
Q1 2024 Apr 30, 2024	BUY	$159.82 - $182.1 $198,975 - $226,714	1,245 Added 13.43%	10,517 $1.92 Million
Q2 2023 Aug 03, 2023	BUY	$132.51 - $164.9 $1,987 - $2,473	15 Added 0.16%	9,272 $1.25 Million
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $74,618 - $85,934	-516 Reduced 5.28%	9,257 $1.48 Million
Q4 2022 Feb 06, 2023	BUY	$138.31 - $165.87 $956,413 - $1.15 Million	6,915 Added 241.95%	9,773 $1.58 Million
Q3 2022 Nov 01, 2022	SELL	$134.21 - $153.93 $882,028 - $1.01 Million	-6,572 Reduced 69.69%	2,858 $384,000
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $45,689 - $58,086	-332 Reduced 3.4%	9,430 $1.44 Million
Q1 2022 May 10, 2022	SELL	$131.98 - $163.75 $791 - $982	-6 Reduced 0.06%	9,762 $1.58 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $10,850 - $13,728	101 Added 1.04%	9,768 $1.32 Million
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $10,108 - $11,474	-95 Reduced 0.97%	9,667 $1.04 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $7,469 - $8,321	71 Added 0.73%	9,762 $1.1 Million
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $26,700 - $29,393	261 Added 2.77%	9,691 $1.05 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $4,829 - $6,520	60 Added 0.64%	9,430 $1.01 Million
Q3 2020 Nov 10, 2020	SELL	$85.91 - $100.83 $18,900 - $22,182	-220 Reduced 2.29%	9,370 $821,000
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $10,198 - $13,647	139 Added 1.47%	9,590 $942,000
Q1 2020 May 11, 2020	BUY	$64.5 - $97.79 $22,639 - $34,324	351 Added 3.86%	9,451 $720,000
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $7,213 - $9,025	-100 Reduced 1.09%	9,100 $806,000
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $4,156 - $4,997	66 Added 0.72%	9,200 $697,000
Q2 2019 Aug 08, 2019	SELL	$65.7 - $83.98 $19,447 - $24,858	-296 Reduced 3.14%	9,134 $664,000
Q1 2019 May 10, 2019	SELL	$77.14 - $90.79 $13,499 - $15,888	-175 Reduced 1.82%	9,430 $760,000
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $5,449 - $6,720	70 Added 0.73%	9,605 $885,000
Q3 2018 Nov 09, 2018	BUY	$88.91 - $98.84 $15,914 - $17,692	179 Added 1.91%	9,535 $902,000
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $83,226 - $98,475	927 Added 11.0%	9,356 $867,000
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $12,881 - $17,249	-140 Reduced 1.63%	8,429 $798,000
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $18,449 - $20,231	-206 Reduced 2.35%	8,569 $829,000
Q3 2017 Nov 20, 2017	BUY	$69.85 - $89.22 $612,933 - $782,905	8,775	8,775 $780,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartline Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Hartline Investment Corp with notifications on news.

Account

Hartline Investment Corp Abb Vie Inc. Transaction History